Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol

Molecular Nutrition and Food Research

Volumn 56, Issue 8, 2012, Pages 1304-1314

  Weng, Chia Jui ^a   Chou, Chai Ping ^b   Ho, Chi Tang ^c   Yen, Gow Chin ^b  

^a TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

6 Gingerol; 6 Shogaol; Angiogenesis; Invasion; Matrix metalloproteinase

Indexed keywords

ANGIOGENESIS INHIBITOR; CATECHOL DERIVATIVE; FATTY ALCOHOL; GELATINASE A; GELATINASE B; GINGEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SERPINE1 PROTEIN, HUMAN; SHOGAOL; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; UROKINASE; VASCULOTROPIN A;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CATECHOLS; FATTY ALCOHOLS; HUMANS; INTERLEUKIN-8; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTO-ONCOGENE PROTEINS C-AKT; RATS; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865117886     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200173     Document Type: Article

References (38)

1. World Health Organization, The World Health Report. WHO, Geneva 2010.
2. Thomas, M. B., Abbruzzese, J. L., Opportunities for targeted therapies in hepatocellular carcinoma. J. Clin. Oncol. 2005, 23, 8093-8108.
3. Mulcahy, M. F., Management of hepatocellular cancer. Curr. Treat. Options Oncol. 2005, 6, 423-435.
4. Chung, A. S., Lee, J., Ferrara, N., Targeting the tumour vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer. 2010, 10, 505-514.
5. Mason, S. D., Joyce, J. A., Proteolytic networks in cancer. Trends Cell Biol. 2011, 21, 228-237.
6. Hildenbrand, R., Allgayer, H., Marx, A., Stroebel, P., Modulators of the urokinase-type plasminogen activation system for cancer. Expert Opin. Investig. Drugs 2010, 19, 641-652.
7. Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H. et al., Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 2008, 34, 122-136.
8. Voorzanger-Rousselot, N., Garnero, P., Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Cancer Treat. Rev. 2007, 33, 230-283.
9. Bergers, G., Benjamin, L. E., Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3, 401-410.
10. Manju, V., Nalini, N., Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, postinitiation stages of 1, 2 dimethylhydrazine-induced colon cancer. Clin. Chim. Acta 2005, 358, 60-67.
11. Lantz, R. C., Chen, G. J., Sarihan, M., Solyom, A. M. et al., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007, 14, 123-128.
12. O'Hara, M., Kiefer, D., Farrell, K., Kemper, K., A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 1998, 7, 523-536.
13. Rhode, J., Fogoros, S., Zick, S., Wahl, H. et al., Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern. Med. 2007, 7, 44-52.
14. Yagihashi, S., Miura, Y., Yagasaki, K., Inhibitory effect of gingerol on the proliferationand invasion of hepatoma cells in culture. Cytotechnology 2008, 57, 129-136.
15. Weng, C. J., Wu, C. F., Huang, H. W., Ho, C. T. et al., Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol. Nutr. Food Res. 2010, 54, 1618-1627.
16. Arnaoutova, I., Kleinman, H. K., In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat. Protoc. 2010, 5, 628-635.
17. Go, R. S., Owen, W. G., The rat aortic ring assay for in vitro study of angiogenesis. Methods Mol. Med. 2003, 85, 59-64.
18. Weng, C. J., Yen, G. C., Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 2012, 38, 76-87.
19. Suzuki, F., Kobayashi, M., Komatsu, Y., Kato, A. et al., Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 1997, 17, 873-878.
20. Ishiguro, K., Ando, T., Maeda, O., Ohmiya, N. et al., Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms. Biochem. Biophys. Res. Commun. 2007, 362, 218-223.
21. Lee, H. S., Seo, E. Y., Kang, N. E., Kim, W. K., [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 2008, 19, 313-319.
22. Ling, H., Yang, H., Tan, S. H., Chui, W. K. et al., 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-kappaB activation. Br. J. Pharmacol. 2010, 161, 1763-1777.
23. Kyung, K. S., Gon, J. H., Geun, K. Y., Sup, J. J. et al., 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. Eur. J. Neurosci. 2006, 24, 1042-1052.
24. Whittaker, S., Marais, R., Zhu, A. X., The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010, 29, 4989-5005.
25. Liu, Y., Liu, A., Li, H., Li, C. et al., Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells. Cancer Prev. Res. (Phila) 2011, 4, 1296-1305.
26. Schneller, D., Machat, G., Sousek, A., Proell, V. et al., p19(ARF)/p14(ARF) controls oncogenic functions of Stat3 in hepatocellular carcinoma. Hepatology 2011, 54, 264-172.
27. Chen, K. F., Tai, W. T., Liu, T. H., Huang, H. P. et al., Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. Clin. Cancer Res. 2010, 16, 5189-5199.
28. Brown, A. C., Shah, C., Liu, J., Pham, J. T. et al., Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytother. Res. 2009, 23, 640-645.
29. Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S. et al., Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J. Natl. Cancer Inst. 2008, 100, 359-372.
30. Ferrara, N., Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev. 2010, 21, 21-26.
31. Rundhaug, J. E., Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 2005, 9, 267-285.
32. Gorantla, B., Asuthkar, S., Rao, J. S., Patel, J. et al., Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Mol. Cancer. Res. 2011, 9, 377-389.
33. Huynh, H., Molecularly targeted therapy in hepatocellular carcinoma. Biochem. Pharmacol. 2010, 80, 550-560.
34. Butturini, E., Cavalieri, E., Carcereri de Prati, A., Darra, E. et al., Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation. PLoS One 2011, 6, e20174.
35. Ramachandran, P. V., Yip-Schneider, M., Schmidt, C. M., Natural and synthetic alpha, beta-unsaturated carbonyls for NF-kappaB inhibition. Future Med. Chem. 2009, 1, 179-200.
36. He, G., Karin, M., NF-kappaB and STAT3-key players in liver inflammation and cancer. Cell Res. 2011, 21, 159-168.
37. Bijman, M. N., van Nieuw Amerongen, G. P., Laurens, N., van Hinsbergh, V. W. et al., Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol. Cancer. Ther. 2006, 5, 2348-2357.
38. Ishiguro, K., Ando, T., Watanabe, O., Goto, H., Specific reaction of alpha, beta-unsaturated carbonyl compounds such as 6-shogaol with sulfhydryl groups in tubulin leading to microtubule damage. FEBS Lett. 2008, 582, 3531-3536.